Homocysteine, B vitamins, and coronary artery disease.
This article discusses the metabolism of homocysteine, factors affecting its plasma level, and the evidence for its role in the pathogenesis of vascular disease. The treatment of hyperhomocysteinemia and its possible impact on vascular disease prevention and progression are described also.
Seshadri
N
N
Department of Cardiology, Cleveland Clinic Foundation, Ohio, USA.
Robinson
K
K
D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000209:etiology* / Q000517:prevention & control; D005492:Folic Acid / Q000008:administration & dosage; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications* / Q000209:etiology; D009203:Myocardial Infarction / Q000209:etiology* / Q000517:prevention & control; D012008:Recurrence; D012307:Risk Factors; D014804:Vitamin B Deficiency / Q000150:complications* / Q000209:etiology
D005492:Folic Acid